Anaplastic lymphoma kinase (ALK), in exosomes secreted by BRAF inhibitor-resistant melanoma cells, has recently been demonstrated to transfer drug resistance by activating the MAPK signaling pathway in recipient cells [191]. This evidence concerns the gene ALK and melanoma.